Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1053352.RALq-kl8-_5Ib0BcvE6HdKNpgciG_1OzFh902KfRgk3eo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1053352.RALq-kl8-_5Ib0BcvE6HdKNpgciG_1OzFh902KfRgk3eo130_assertion type Assertion NP1053352.RALq-kl8-_5Ib0BcvE6HdKNpgciG_1OzFh902KfRgk3eo130_head.
- NP1053352.RALq-kl8-_5Ib0BcvE6HdKNpgciG_1OzFh902KfRgk3eo130_assertion description "[After 3 months of therapy, levels of left ventricular end diastolic diameter, NT-proBNP, CRP, Th1, Th1/Th2, IFN-?, T-bet mRNA and T-bet/GATA-3 mRNA decreased in the two CCI subgroups, but levels in the CCI intervention group were lower in comparison to the control group.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1053352.RALq-kl8-_5Ib0BcvE6HdKNpgciG_1OzFh902KfRgk3eo130_provenance.
- NP1053352.RALq-kl8-_5Ib0BcvE6HdKNpgciG_1OzFh902KfRgk3eo130_assertion evidence source_evidence_literature NP1053352.RALq-kl8-_5Ib0BcvE6HdKNpgciG_1OzFh902KfRgk3eo130_provenance.
- NP1053352.RALq-kl8-_5Ib0BcvE6HdKNpgciG_1OzFh902KfRgk3eo130_assertion SIO_000772 23413906 NP1053352.RALq-kl8-_5Ib0BcvE6HdKNpgciG_1OzFh902KfRgk3eo130_provenance.
- NP1053352.RALq-kl8-_5Ib0BcvE6HdKNpgciG_1OzFh902KfRgk3eo130_assertion wasDerivedFrom befree-2016 NP1053352.RALq-kl8-_5Ib0BcvE6HdKNpgciG_1OzFh902KfRgk3eo130_provenance.
- NP1053352.RALq-kl8-_5Ib0BcvE6HdKNpgciG_1OzFh902KfRgk3eo130_assertion wasGeneratedBy ECO_0000203 NP1053352.RALq-kl8-_5Ib0BcvE6HdKNpgciG_1OzFh902KfRgk3eo130_provenance.